![](https://iqs.edu/app/uploads/2024/02/iqs-chemsynbio.jpg)
In the ChemSynBio group (Chemical & Synthetic Biology for Biotherapies) we combine the power of chemical and synthetic biology to create protein-based precision therapeutics and biomedical tools. Our main goals are to treat brain tumors and other brain diseases, and to understand and improve drug transport across the blood-brain barrier.
ChemSynBio investiga y trabaja en transferencia de tecnología en la siguientes áreas:
- Development of bio- and nano- therapeutics, especially to treat brain tumors.
- Engineering and chemistry of antibodies, proteins, and peptides for biomedical applications.
- Study and engineering of transport systems to cross the blood-brain barrier.
- Development of conditionally-active proteins.
- Generation of new proteins through library selections and directed evolution.
![](https://iqs.edu/app/uploads/2024/02/iqs-grup-investigacio-chemsynbio-2023-002-1024x577.jpg)
External colaborators
Sally Ward, PhD
University of SouthamptonManuel Valiente, PhD
Centro Nacional de Investigaciones Oncológicas (CNIO)David Baker, PhD
University of WashingtonBioengineering Department of IQS
Roberta Lucchi, Maria C Lucana, Montserrat Escobar, Pol Martín, Pedro Canhao, Adrià Puigdemont, Burcu Yaldiz